Clinical Protocol of Human Gene Transfer for Hemophilia B. Fudan University, Shanghai, China

Human Gene Therapy

Volumn 3, Issue 5, 1992, Pages 543-552

  Hsueh, Jerry L ^a   Xingfang, Qiu ^a   Jiemin, Zhou ^a   Yifan, Dan ^a   Yiping, Hu ^a   Daru, Lu ^a   Xingbin, Al ^a   Bing, Zheng ^a   Zuoshu, Jiang ^a   Xiaopeng, Wang ^a   Peilin, Meng ^a   Bihe, Min ^a   Jianmin, Wang ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9;

ADOLESCENT; ARTICLE; CELL CULTURE; CHILD; CLINICAL PROTOCOL; DNA VECTOR; FIBROBLAST; GENETIC TRANSFECTION; GENETICS; HEMOPHILIA B; HUMAN; MALE; RETROVIRUS; TRANSPLANTATION;

ADOLESCENT; CELLS, CULTURED; CHILD; CLINICAL PROTOCOLS; FACTOR IX; FIBROBLASTS; GENETIC VECTORS; HEMOPHILIA B; HUMAN; MALE; RETROVIRIDAE; TRANSFECTION;

EID: 0026941539     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.1992.3.5-543     Document Type: Article

References (38)

1. Anderson, W.F., 1984, Prospects for human gene therapy. Science, 226: 401–408.
2. Belmont, J.W. & Caskey, G.T., 1986, Development leading to human gene therapy. In: Gene transfer, pp 411–441, R. Kucherla-pati (eds.) Plenum Press, New York & London.
3. Ledley, F.D., 1987, Somatic gene therapy for human disease: Background and prospects (Part I and Part II). J. Pediatrics, 110: 1–8; 167–174.
4. Friedmann, T., 1989, Progress toward human gene therapy. Science, 244: 1275–1287.
5. Verma, I.M., 1990, Gene therapy. Scientific American, 26(5): 68–72; 81–84.
6. Weiss, R., 1990, First human gene-therapy test begun. Science News, 138: 180.
7. Anderson, W.F., 1990, September 14, 1990: the beginning. Hum. GeneTher. 1:371–372.
8. Miller, A.D., et al, 1985, Generation of helper-free amphotropic retrovirus that transduce a dominant-acting, methotrexate resistant dihydrofolate reductase gene. Mol. Cell. Biol. 5: 431–437.
9. Miller, A.D., et al, 1986, Factors involved in production of helper virus-free retrovirus vectors. Somat. Cell Mol. Gent. 12: 175–183.
10. Armentano, D., et al, 1987, Effect of internal sequence on the utility of retroviral vector. J. Virol. 61: 1647–1650.
11. Hantzopoulos, P.A., et al, 1989, Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. PNAS, 86: 3519–3523.
12. Miller, A.D. & Baltimore, C., 1986, Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6: 2895–2902.
13. Belmont, J.W., et al, 1988, Expression of human adenosine deaminase in murine hematopoietic cells. Mol. Cell. Biol. 8: 5116–5125.
14. Anson, D.S., et al, 1987, Towards gene therapy for hemophilia B. Mol. Biol. Med. 4: 11–20.
15. St. Louis, D. & Verma, I.M., 1988, An alternative approach to somatic cell gene therapy. PNAS, 83: 3150–3154.
16. Palmer, T.D., et al, 1989, Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood, 73: 438–445.
17. Armentano, D., et al, 1990, Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. PNAS, 87: 6141–6145.
18. Culver, K.W., et al, 1991, Correction of ADA deficiency in human T lymphocytes using retrovirus-mediated gene transfer. Transplantation Proceedings, 23: 170–171.
19. Weiss, R., 1990, Early results of gene therapy encouraging. Science New, 138:388.
20. Anson, D.S., et al, 1985, Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells. Nature, 315:683–685.
21. Busby, S., et al, 1985, Expression of active human factor IX in transfected cells. Nature, 316: 271–273.
22. Choo, K.H., et al, 1987, Expression of active human blood clotting factor IX in transgenic mice: Use of a cDNA with complete mRNA sequence. Nuc. Acid. Res. 15: 871–884.
23. Kaufman, R.J., et al, 1986, Expression, purification, and characterization in Chinese hamster ovary cells. J. Biol. Chem. 261: 9622–9628.
24. de la Salle, H., et al, 1985, Active r-carboxylated human factor IX expressed using recombinant DNA techniques. Nature, 316: 268–270.
25. Axelrod, J.H., et al, 1990, Phenotype correction of factor IX deficiency in skin fibroblasts of hemophilia dog. PNAS, 87: 5173–5177.
26. Boshart, M., et al., 1985, A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell, 41: 521–530.
27. Smith, K.J., et al, 1987, Factor IX metal ion-dependent antigen assays for measurement of warfarin effect. Am. J. Clin. Pathol. 87: 370–376.
28. Blaese, R.M., et al, 1990, The ADA Human Gene Therapy Clinical Protocol. Hum. Gene Ther. 1: 327–329.
29. Rosenberg, S.A., et al, 1990, The N2-TIL Human Gene Transfer Clinical Protocol. Hum. Gene Ther. 1: 73–92.
30. Starzl, T.E., et al, 1989, Medical Progress/Liver Transplantation. N. Engl. J. Med. 321: 1014–1022 & 1092–1099.
31. Dai, Yifan, et al, 1990. Detection of human clotting factor IX antigen by a double antibody ELISA. Journal of Fudan University (Natural Science) 29 (4): 413–417.
32. Zhou, Jiemin, et al, 1990, Rapid Detection of Exogenous Human Clotting Factor IX cDNA in Transferred Cells by Polymerase Chain Reaction. Chinese Science Bulletin 35 (23): 1995–1999.
33. Wang, Pin, et al, 1991, High Expression of Human Factor IX cDNA Driven by HCMV Promoter in Mammalian Cells. Chinese Science Bulletin 37 (1): 52–55.
34. Zhou, Jiemin, et al, 1992, The Construction of Human Factor IX Recombinant Plasmid and the Expression of the Transforming Cell Graft in Mouse. Chinese Science Bulletin (in press).
35. Zhou, Jiemin, et al, 1992, The Lasting Expression of Human Factor IX cDNA in Rabbit. Science in China (Series B) (to be published).
36. Zhou, Jiemin, Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a Hemophilia B patient. Science in China May, 1992.
37. Dai, Yifan, et al, 1992, High Efficient Transfer and Expression of Human Clotting Factor IX cDNA in Cultured Human Primary Skin Fibroblasts from Hemophilia B Patient by Retroviral Vectors. Science in China (Series B) Vol. 35 No. 2 183–193.
38. Diagnosis of Hematopathy and the Criteria for Treating Efficacy (p 269, 1st edition, 1991) published by the Tianjin Science and Technology Publishing House.